APLS
Price
$20.06
Change
+$0.85 (+4.42%)
Updated
May 1, 04:59 PM (EDT)
Capitalization
2.52B
Earnings call today
BLTE
Price
$61.70
Change
+$0.22 (+0.36%)
Updated
May 1, 04:59 PM (EDT)
Capitalization
2B
6 days until earnings call
Ad is loading...

APLS vs BLTE

Header iconAPLS vs BLTE Comparison
Open Charts APLS vs BLTEBanner chart's image
Apellis Pharmaceuticals
Price$20.06
Change+$0.85 (+4.42%)
Volume$84.66K
Capitalization2.52B
Belite Bio
Price$61.70
Change+$0.22 (+0.36%)
Volume$800
Capitalization2B
APLS vs BLTE Comparison Chart
Loading...
APLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APLS vs. BLTE commentary
May 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLS is a Buy and BLTE is a Buy.

Ad is loading...
COMPARISON
Comparison
May 02, 2025
Stock price -- (APLS: $19.21 vs. BLTE: $61.70)
Brand notoriety: APLS and BLTE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLS: 116% vs. BLTE: 24%
Market capitalization -- APLS: $2.41B vs. BLTE: $2.01B
APLS [@Biotechnology] is valued at $2.41B. BLTE’s [@Biotechnology] market capitalization is $2.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLS’s FA Score shows that 0 FA rating(s) are green whileBLTE’s FA Score has 0 green FA rating(s).

  • APLS’s FA Score: 0 green, 5 red.
  • BLTE’s FA Score: 0 green, 5 red.
According to our system of comparison, BLTE is a better buy in the long-term than APLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLS’s TA Score shows that 6 TA indicator(s) are bullish while BLTE’s TA Score has 5 bullish TA indicator(s).

  • APLS’s TA Score: 6 bullish, 2 bearish.
  • BLTE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, APLS is a better buy in the short-term than BLTE.

Price Growth

APLS (@Biotechnology) experienced а +9.83% price change this week, while BLTE (@Biotechnology) price change was +4.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.98%. For the same industry, the average monthly price growth was +8.35%, and the average quarterly price growth was -7.74%.

Reported Earning Dates

APLS is expected to report earnings on Aug 11, 2025.

BLTE is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+2.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APLS($2.52B) has a higher market cap than BLTE($2B). BLTE YTD gains are higher at: -2.219 vs. APLS (-39.799). BLTE has higher annual earnings (EBITDA): -35.42M vs. APLS (-154.53M). APLS has higher revenues than BLTE: APLS (781M) vs BLTE (0).
APLSBLTEAPLS / BLTE
Capitalization2.52B2B126%
EBITDA-154.53M-35.42M436%
Gain YTD-39.799-2.2191,794%
P/E RatioN/AN/A-
Revenue781M0-
Total Cash411MN/A-
Total Debt470MN/A-
FUNDAMENTALS RATINGS
APLS: Fundamental Ratings
APLS
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APLSBLTE
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 3 days ago
75%
Declines
ODDS (%)
Bearish Trend 10 days ago
79%
Bearish Trend 11 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Ad is loading...
APLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APHTX21.710.04
+0.18%
Artisan Focus Fund Institutional
FSFWX64.560.08
+0.12%
American Funds SMALLCAP World 529-F-3
LSRCX1.66N/A
N/A
Lord Abbett Small Cap Value C
PRUAX15.25N/A
N/A
PGIM Jennison Utility A
LBWAX19.76N/A
N/A
BrandywineGLOBAL Div US Large Value A

APLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLS has been loosely correlated with ROIV. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if APLS jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLS
1D Price
Change %
APLS100%
+5.49%
ROIV - APLS
47%
Loosely correlated
+2.79%
BEAM - APLS
44%
Loosely correlated
+1.01%
NTLA - APLS
43%
Loosely correlated
+7.93%
IGMS - APLS
41%
Loosely correlated
+5.34%
CRSP - APLS
41%
Loosely correlated
+3.40%
More

BLTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLTE has been loosely correlated with RAIN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BLTE jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLTE
1D Price
Change %
BLTE100%
-0.96%
RAIN - BLTE
48%
Loosely correlated
+23.81%
ACOG - BLTE
24%
Poorly correlated
+2.75%
ALEC - BLTE
24%
Poorly correlated
+4.87%
TVTX - BLTE
23%
Poorly correlated
+3.54%
KALA - BLTE
22%
Poorly correlated
-7.06%
More